Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

333
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
333
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.8K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roles of NRXN1 in neuropsychiatric disorders: from genetic lesion to molecular mechanism.

Frontiers in neuroscience·2026
Same author

Knowledge graph-based cognitive learning with multi-fact reasoning.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

IIC-DTI: A Contrastive Learning Enhanced Inter-Intra Molecular Fusing Framework for Drug-Target Interaction Prediction.

Interdisciplinary sciences, computational life sciences·2026
Same author

RCVQA: Visual question answering model based on reading comprehension.

Neural networks : the official journal of the International Neural Network Society·2025
Same author

Graph convolution network based on meta-paths and mutual information for drug-target interaction prediction.

BMC bioinformatics·2025
Same author

The study of the variation of mineral distribution and relative concentration on varieties of oat using synchrotron-based X-ray fluorescence imaging.

Food research international (Ottawa, Ont.)·2025

Related Experiment Video

Updated: Jun 13, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

983

GIAE-DTI: Predicting Drug-Target Interactions Based on Heterogeneous Network and GIN-Based Graph Autoencoder.

Mengdi Wang, Xiujuan Lei, Lian Liu

    IEEE Journal of Biomedical and Health Informatics
    |September 11, 2024
    PubMed
    Summary

    This study introduces GIAE-DTI, a novel deep learning framework for predicting drug-target interactions (DTIs). It effectively addresses data sparsity and improves information aggregation, outperforming existing methods in DTI prediction.

    More Related Videos

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.1K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.5K

    Related Experiment Videos

    Last Updated: Jun 13, 2025

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    983
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.1K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.5K

    Area of Science:

    • Computational chemistry
    • Bioinformatics
    • Machine learning

    Background:

    • Accurate drug-target interaction (DTI) prediction is crucial for drug discovery and repurposing.
    • Existing computational methods struggle with sparse DTI data, limiting their ability to aggregate neighbor node information and represent isolated nodes.

    Purpose of the Study:

    • To develop a novel deep learning framework, GIAE-DTI, for enhanced DTI prediction.
    • To address the limitations of existing methods in handling sparse DTI data and improve information aggregation.

    Main Methods:

    • Constructed a heterogeneous network incorporating drug-drug, protein-protein, and weighted K-nearest neighbor processed drug-target interactions.
    • Employed a graph autoencoder with a graph isomorphism network for feature extraction and a dual decoder for self-supervised learning.
    • Utilized a deep neural network for final DTI prediction based on learned latent representations.

    Main Results:

    • GIAE-DTI achieved AUC of 0.9533 and AUPR of 0.9619 on a benchmark dataset, surpassing current state-of-the-art methods.
    • Demonstrated practical applicability through case studies involving 5-hydroxytryptamine receptor targets and drugs for mental diseases.

    Conclusions:

    • GIAE-DTI offers a robust and effective approach for DTI prediction, particularly in scenarios with sparse data.
    • The framework shows significant potential for accelerating drug discovery and repurposing efforts.